Standard Therapy
Standard Therapy is a pharmaceutical drug with 145 clinical trials. Currently 16 active trials ongoing. Historical success rate of 82.1%.
Success Metrics
Based on 64 completed trials
Phase Distribution
Phase Distribution
14
Early Stage
34
Mid Stage
36
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
73.6%
64 of 87 finished
26.4%
23 ended early
16
trials recruiting
145
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
iNO300 Therapy in Critically Ill Patients With Pneumonia
Stem Cell and Conditioned Medium for Cerebral Palsy
SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
Clinical Trials (145)
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
iNO300 Therapy in Critically Ill Patients With Pneumonia
Stem Cell and Conditioned Medium for Cerebral Palsy
SGLT2 Inhibitors in Adult Primary Nephrotic Syndrome
Application of mRNA Immunotherapy Technology in EB Virus Related Diseases
Lactobacillus Acidophilus and Limosilactobacillus Reuteri for Acute Diarrhea in Children
Non-Invasive Brain-Computer Interface Combined With Transcranial Electrical Stimulation for Peripheral Facial PalsyStimulation in the Treatment of Peripheral Facial Palsy
Aggressive Local Therapy for Limited Bone-Only Metastasis to Improve Progression-Free Survival in Breast Cancer Patients
Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease
Cilostazol in the Treatment of Nonalcoholic Fatty Liver Disease
Contribution of Nasal High Flow in Pneumology Assessed in Acid-Free Hypercapnic Acute Respiratory Failure
Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD
Randomized Phase-II Study of Nivolumab Plus Ipilimumab vs. Standard of Care in Untreated and Advanced Non-clear Cell RCC
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer
Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE)
Effect of Acupuncture on Hemodynamics and Pain of Post Craniotomy Patients With Mechanical Ventilation
The Efficacy of Self-Manufactured 40% Dextrose Gel in Asymptomatic Transient Neonatal Hypoglycemia Treatment
Clinical Study on Nanocrystalline Megestrol Acetate for Appetite Improvement and Weight Gain in Pre-Cachexia and Cachexia Stages Key Terminology Analysis
Clinical Study on Fecal Microbiota Transplantation for Diarrhea After Total Pancreatectomy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 145